Global Transplantation Market Size By Product Type (Immunosuppressive Drugs, Tissue Products, Preservation Solution), By Application (Tissue Transplantation, Organ Transplantation), By Geographic Scope And Forecast

Transplantation Market Size And Forecast

Transplantation Market size was valued at USD 15.25 Billion in 2022 and is projected to reach USD 31.2 Billion by 2030, growing at a CAGR of 9.62% from 2023 to 2030.

One of the major factors driving the market expansion is the surging need for organ transplantation to treat organ failure and novel tissue transplantation products. Organ failure typically results from a variety of causes, including severe trauma, blood loss, poisoning, drug misuse, leukemia, sepsis, and other acute illnesses. Globally, there is a strong need for transplants of tissues and organs, particularly those of the kidney, heart, liver, and lungs. Organ failure can be brought on by a variety of factors, including drinking alcohol, poor eating habits, drug abuse, and lack of exercise. Thus, the demand for transplantation products is expected to rise in the coming years. The Global Transplantation Market report delivers a holistic evaluation. The report thoroughly analyzes key segments, trends, drivers, restraints, competitive landscape, and factors that play a substantial role in the market.

Global Transplantation Market Definition

Organ transplantation is one of the most significant medical advancements in the world. In this medical process, an organ or tissue is surgically removed from one person (the organ donor) and placed into another person (the organ recipient). It is possible to transplant human organs such as the lung, liver, kidney, pancreas, cornea, and skin. Transplants help patients have healthy lives and restore their bodies to normal. The success rate of transplants has increased due to technological developments. Moreover, convenient software and systems for tissue and organ preservation are available.

Global Transplantation Market Overview

An increase in the prevalence of acute diseases, which in turn leads to an increase in the number of organ failures, can be attributed for the global rise in the demand for organs to be transplanted. For instance, diabetes and high blood pressure are the most frequent causes of end-stage renal disease, for which the only curative choices are kidney transplantation or dialysis. The U.S. Department of Health & Human Services estimated that in 2019, there were around 122,913 people in the country who were in need of organ transplants. As a result, there is a huge demand for cutting-edge transplantation products to address organ failure.

The introduction of technologically advanced products and the rise in the number of tissue banks are some of the major factors driving the growth of the market. However, some of the constraints, such as the lack of organ donors for transplant surgeries, are anticipated to slow market expansion. The supply and demand of organs for treating organ failure are vastly out of balance. The U.S. Department of Health & Human Services estimates that there were about 43,201 Americans in need of kidney transplants in 2019. However, only 23,401 kidney transplant operations were carried out in 2019. Many people are discouraged from making donations due to a lack of understanding about organ donation as well as religious and cultural beliefs. As a result, it is anticipated that the lack of organs for the treatment of organ failure will negatively impact market expansion.

Global Transplantation Market Segmentation Analysis

The Global Transplantation Market is segmented on the Basis of Product Type, Application, End Use, and Geography.

Transplantation Market, By Product Type

• Immunosuppressive Drugs
• Tissue Products
• Preservation Solution

Based on the Product Type, the market for Transplantation is bifurcated into immunosuppressive drugs, tissue products, and preservation solutions. Tissue products are anticipated to make up the majority of the total revenue share during the anticipated period. Immunosuppressants, preservation solutions, and tissue products are the main products utilized in tissue or organ transplantation. The segment’s expansion is attributable to the rise in transplantations of orthopedic soft tissues, heart valves, bone marrow, cochlear implants, and other organs. Additionally, new product development is also expected to trigger market growth.

The market for immunosuppressive drugs is anticipated to increase significantly during the projection period. This can be attributed to the widespread use of these drugs to prevent the rejection of post-transplant tissue or organs. The need for organ replacement has increased significantly as a result of the rising prevalence of chronic diseases.

Due to growing government support for stem cell research and the widespread use of these products to enhance the physiological function of organs, the preservation solutions segment is anticipated to experience considerable expansion during the forecast period. Also, the sector is expected to develop as a result of an increase in organ failure instances, organ transplant operations, and global organ donation rates.

Transplantation Market, By Application

• Tissue Transplantation
• Organ Transplantation

Based on the Application, the Market for Transplantation is bifurcated into tissue transplantation and organ transplantation. The tissue transplantation segment dominated the major market share in 2022, owing to the fact that the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are most commonly performed procedure worldwide. The demand for tissue products is anticipated to increase as a result of the rise in burn and accident cases. For instance, according to the European Road Safety Observatory report Spain reported 102,362 injury accidents, resulting in an increase in demand for tissue transplants.

Transplantation Market, By End Use

• Transplant Centers
•  Hospitals
• Others

Based on the End Use, the Market for Transplantation is bifurcated into Transplant Centers, Hospitals, And Others.

Transplantation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Regional Analysis, The Transplantation Market is classified into North America, Europe, Asia Pacific, And the Rest of the World. In 2022, North America held the major market share of the Transplantation Market and is predicted to maintain its dominance throughout the projected period. The expansion of the market is being supported by highly developed healthcare facilities and the local presence of numerous major biotechnology and medical device companies, including Stryker, Arthrex, Inc., Zimmer Biomet, Medtronic, and Novartis AG.

Furthermore, the Asia Pacific region is projected to grow at the highest CAGR over the forecast period, owing to expanding stem cell research to create in-vitro tissue and organs as well as improving healthcare infrastructure in Asian countries like India, Thailand, the Philippines, and Indonesia.

Key Players

The “Global Transplantation Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Arthrex Inc, Medtronic PLC, Zimmer Biomet, Strykers, Novartis AG, Abbvie Inc, BiolifeSolutions Inc, 21st Century Medicine, Teva Pharmaceuticals, Veloxis Pharmaceutical, and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight to the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2022, In order to distribute Genex Bone Graft Substitute with its novel mixing technology and delivery options exclusively in the United States, Zimmer Biomet and Biocomposites engaged in a multi-year partnership.
• In January 2021, Novartis and Alnylam announced a strategic partnership to leverage Alnylam’s siRNA technology to inhibit a target discovered at the Novartis Institutes for BioMedical Research. This collaboration may result in the creation of therapy to encourage the regrowth of functional liver cells and offer patients with liver failure an alternative to transplantation.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Transplantation market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Transplantation Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research